Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs

Nanovalve平台：靶向、可控、释放抗癌药物

• 批准号: 8206804
• 负责人: Andre Elias Nel
• 金额: $ 39.36万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8206804
• 关键词: Adriamycin PFS; Antineoplastic Agents; Apoptosis; California; Camptothecin; Cancer cell line; Cell Death; Cell Line; Cell membrane; Cells; Chemotherapy-Oncologic Procedure; Confocal Microscopy; Constitution; Coumarins; DNA Binding; DNA Binding Agent; Doxorubicin; Drug Delivery Systems; Dyes; Environment; Folate; Goals; Human; Injection of therapeutic agent; Institutes; Investigation; Label; Laboratories; Ligands; Light; Malignant Epithelial Cell; Molecular Machines; Mus; Natural Killer Cells; Nude Mice; Paclitaxel; Performance; Pharmaceutical Preparations; Principal Investigator; Propidium Diiodide; Proteins; Pseudorotaxanes; Research; Research Personnel; Silicon Dioxide; Site; Solid; Solutions; Stimulus; Structure; Surface; System; Testing; Universities; alpha benzopyrone; aqueous; azobenzene; cancer cell; cancer therapy; capsule; chemotherapeutic agent; controlled release; design; improved; improved functioning; light effects; mouse model; nano; nanomachine; nanoparticle; nanosystems; novel; novel strategies; operation; particle; public health relevance; response; skills; subcutaneous; targeted delivery; tissue culture; tumor; tumor growth; tumor xenograft; uptake

DESCRIPTION (provided by applicant): The goal of the proposed research is to use mesoporous silica nanoparticles with bistable molecular machines to deliver anticancer drugs. The active structures are nanomachines that consist of a solid silica support that contains designed pores, and moving parts that trap drug molecules and release them from the pores only on external command or under desired conditions. Two types of machines, nanoimpellers that actively eject molecules from the pores, and nanovalves that block and unblock the entrances to the pores will be used to control the delivery of drugs. The assembly is coated with molecules or proteins that target the capsules to cancer cells. The first specific aim is to improve and optimize nanomachines (a pH activated valve, a light-activated impeller, a light activated valve) that were developed in the principal investigators laboratories, modify the surfaces for specific cancer cell targeting, and optimize their performance. The second aim will demonstrate operation of the machines in human cancer cells by studying the release of a fluorescent DNA binding agent and to demonstrate the delivery and on-demand release of anticancer drugs (paclitaxel, camptothecin and doxorubicin) in human carcinoma cell lines. Finally, the third aim will evaluate and utilize the nanoparticles in human tumor xenografts grown in athymic mice. By having the valves open only in a tumor, it will be possible to achieve release of anticancer drugs only at specific sites or in response to specific stimuli, thus eliminating unwanted effects on non-cancerous cells. The nano valves and impellers allow sophisticated control of the delivery of the drugs. PUBLIC HEALTH RELEVANCE: Nanoparticles that contain pores controlled by molecular machines will be used to release anticancer drugs under control. The result of the research will be a novel system for cancer chemotherapy that eliminates unwanted effects on non-cancerous cells.

描述（由申请人提供）：拟议研究的目标是使用介孔二氧化硅纳米颗粒和双稳分子机器来输送抗癌药物。活性结构是纳米机器，由含有设计孔的固体二氧化硅支撑和活动部件组成，这些部件可以捕获药物分子，并仅在外部命令或所需条件下将其从孔中释放出来。两种机器将被用于控制药物的输送，一种是主动将分子从毛孔中喷射出来的纳米叶轮，另一种是堵塞和疏通毛孔入口的纳米阀。这个组装体被分子或蛋白质包裹，这些分子或蛋白质将胶囊靶向癌细胞。第一个具体目标是改进和优化在主要研究人员实验室开发的纳米机器（pH激活阀，光激活叶轮，光激活阀），修改特定癌细胞靶向的表面，并优化其性能。第二个目标是通过研究荧光DNA结合剂的释放来演示机器在人类癌细胞中的操作，并演示抗癌药物（紫杉醇、喜树碱和阿霉素）在人类癌细胞系中的传递和按需释放。最后，第三个目标是评估纳米颗粒在胸腺小鼠体内生长的人类肿瘤异种移植物中的应用。通过仅在肿瘤中打开瓣膜，将有可能仅在特定部位或对特定刺激作出反应时释放抗癌药物，从而消除对非癌细胞的有害影响。纳米阀门和叶轮可以对药物的输送进行复杂的控制。